General Flashcards
pathogen to cover for impetigo/ecthyma + treatment duration
s. aureus + some grp A strep
*just impetigo: give topical mupirocin BD x5d
impetigo/ecthyma: 7d
what penicillin abx to give for GAS vs s. aureus
GAS: amoxicillin/ pen V
S. aureus: cloxacillin, cephalexin
what penicillin abx to give for GAS vs strep pneumo
GAS: amoxicillin/ pen v
Strep pneumo: pen v, amox, amoxi-clav, piptazo (penicillins: only cloxacillin does not cover strep pneumo); cephalexin, cefuroxime, ceftriaxone, cefepime, ceftaroline (ceftazidime is the only ceph that does not cover strep pneumo)
pathogen to cover for nonpurulent cellulitis + treatment duration
cellulitis: deeper tissue involvement -> beta-haemolytic strep (GAS)
*if severe (failed therapy/ immunocompromised) consider MRSA risk factors (IV vanco, dapto, linezolid), consider IV (piptazo, cefepime, meropenem)
IF water exposure -> cover for pseudomonas, vibrio, aeromonas -> cipro 500mg BD
5-10d therapy duration (up: 14d if immunocompromised)
pathogen to cover for purulent cellulitis + treatment duration
*purulent: incision & drainage as first-line therapy
-> also indicates s. aureus coverage needed
s. aureus & beta haemolytic strep (GAS) -> start giving abx when moderate (systemic symptoms)
*if skin abscess: cover for pseudomonas + anaerobe -> amoxi-clav (piptazo for long-term stay, carbapenem if more severe)
5-10d treatment duration
DFI pathogen to cover + treatment duration
*clinical presentation: purulent discharge
mild (erythema <2cm around ulcer, NO signs of systemic infection): staph aureus + strep
duration: 1-2 weeks
moderate (erythema >2cm around ulcer, NO signs of systemic infection - deeper tissue infection)
ADD ON gram -ve (+/- pseudomonas) + anaerobes
[amoxi-clav | cefazolin/ceftriaxone + metronidazole]
^these do not cover P. aeruginosa
*consider MRSA risk
duration: 1-3 weeks
severe (erythema >2cm around ulcer WITH signs of systemic infection)
COVER P. aeruginosa -> piptazo| cefepime + metronidazole
*consider MRSA risk
duration: 2-4 weeks
*consider surgery with bone involvement:
- if infected bone + surrounding tissues removed COMPLETELY -> 2-5d abx
- if residual infected tissue -> 1-3 weeks
- if residual viable bone -> 4-6weeks
- if residual dead bone -> >3months
**DO NOT CONTINUE ABX UNTIL WOUND HEALING
pathogen to cover for pharyngitis + treatment duration
GAS -> pen V, amoxicillin
duration: 10d
pathogen to cover for acute rhinosinusitis + treatment duration
Strep pneumo + haemophilus influenzae -> amoxi-clav / amox (if no H. influenzae)
(cloxacillin does not cover for strep penumo)
*some: s. pyogenes, moraxella caterrhalis, anaerobic bacteria
duration: 5-7d
pathogen to cover for outpt CAP w no comorbidities
strep pneumo -> amox/ respi FQ (levo/moxi)
duration: minimum 5d
pathogen to cover for outpt CAP WITH comorbidities
strep pneumo
Haemophilus influenzae
atypicals
-> beta lactam (amoxi-clav, cefuroxime) + macrolide/doxycycline (azithro/ clarithro) OR respi FQs (levo/moxi)
pathogen to cover for inpt NONSEVERE CAP
strep pneumo + H. influenzae + atypical
*consider MRSA, P. aeruginosa risk factors
beta-lactam(amoxi-clav/ cefuroxime) + macrolide/doxycycline/ respi FQs
if MRSA: add IV vanco OR PO/IV linezolid
if P.aeruginosa: modify to include [piptazo, cefepime, ceftazidime, meropenem/ levo]
*ceftazidime does not cover strep pneumo, need beta lactam to ensure coverage
duration: minimum 5d
pathogen to cover for inpt SEVERE CAP
strep pneumo+ H. influenzae + atypicals
PLUS
S. aureus + BURKHOLDERIA PSEUDOMALLEI + Klebsiella pneumonia
beta lactam + CEFTAZIDIME + macrolide
OR
respi FQ + CEFTAZIDIME
*if MRSA/ P. aeruginosa risk factors -> add on vanco/linezolid // ensure ceftazidime/levo in regimen
*LUNG ABSCESS: ANAEROBE COVERAGE (IV/PO clindamycin OR metronidazole)
duration: minimum 5d
pathogen to cover for VAP/HAP + treatment duration
pathogen: S. aureus, P. aeruginosa, enterobacterales (e.coli/ kleb/ proteus)
*cover MRSA based on risk factor
*if p. aeruginosa risk factor -> DOUBLE antipseudomonal agents required
(beta-lactam AND/OR FQs)
*aminoglycosides should not be the sole antipseudomonal agent
Duration: 7d (regardless of pathogen)
pathogen to cover for uncomplicated/ community-acquired UTI + treatment duration
E. coli (>85%), S. saprophyticus (5-15%), gut enterobactericeae (enterococcus faecalis, klebsiella pneumoniae, proteus)
-> nitrofurantoin (5d)/ bactrim (3d)/ fosfomycin(1 dose)/ beta-lactam(5-7d)/ FQs (3d)
pathogen to cover for COMPLICATED /healthcare- associated UTI
E.coli (~50%), enterococci, proteus, klebsiella, enterobacter, p. aeruginosa
-> IV imi/mero, IV cefepime + amikacin, PO cipro/levo (less sick)
*CA-UTI: IV imi/mero/cefepime+amikacin, PO/IV levo x5d (mild), PO bactrim x3d (women <65 w/o upper UTI symptoms after catheter removed)